AVANT Immunotherapeutics, Inc. Invites You to Join First Quarter Earnings Live Conference Call on the Web

Apr 26, 2001, 01:00 ET from AVANT Immunotherapeutics, Inc.

    NEEDHAM, Mass., April 26 /PRNewswire/ -- In conjunction with AVANT
 Immunotherapeutics, Inc.'s (Nasdaq: AVAN) First Quarter Earnings, you are
 invited to listen to its conference call that will be broadcast live over the
 Internet on Thursday, April 26, 2001 at 11:00am Eastern Time.
 
     What:    AVANT Immunotherapeutics, Inc. First Quarter Earnings
 
     When:    Thursday, April 26, 2001 at 11:00am Eastern Time
 
     Where:   http://www.videonewswire.com/AVANT/042601
 
     How:     Live over the Internet -- Simply log on to the web at the address
              above
 
     The webcast will be listen-only. To ask questions you are invited to
 participate by phone. Within the U.S. dial 800-818-9097. International callers
 dial 785-749-3918.  Caller ID for both is AVANT.
 
     Contact:  Chip Catlin, 781-433-3148
 
     AVANT Immunotherapeutics, Inc. is engaged in the discovery, development
 and commercialization of products that harness the human immune response to
 prevent and treat disease. The company's most advanced therapeutic program
 focuses on compounds with the potential to inhibit inappropriate activation of
 the complement cascade, a vital part of the body's immune defense system.
 AVANT is also developing on its own a portfolio of oral vaccines aimed at
 protecting travelers from diseases endemic in developing areas, as well as a
 proprietary therapeutic vaccine for the management of cholesterol. Through
 corporate collaborations, the company is additionally developing a variety of
 infectious disease vaccines.
 Additional information on AVANT Immunotherapeutics, Inc. can be obtained
 through the Company's site on the World Wide Web: http://www.avantimmune.com.
     (Minimum Requirements to listen to broadcast: The RealPlayer software,
 downloadable free from www.real.com/products/player/index.html, and at least a
 14.4Kbps connection to the Internet.  If you experience problems listening to
 the broadcast, send an email to webmaster@vdat.com.)
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X48329756
 
 

SOURCE AVANT Immunotherapeutics, Inc.
    NEEDHAM, Mass., April 26 /PRNewswire/ -- In conjunction with AVANT
 Immunotherapeutics, Inc.'s (Nasdaq: AVAN) First Quarter Earnings, you are
 invited to listen to its conference call that will be broadcast live over the
 Internet on Thursday, April 26, 2001 at 11:00am Eastern Time.
 
     What:    AVANT Immunotherapeutics, Inc. First Quarter Earnings
 
     When:    Thursday, April 26, 2001 at 11:00am Eastern Time
 
     Where:   http://www.videonewswire.com/AVANT/042601
 
     How:     Live over the Internet -- Simply log on to the web at the address
              above
 
     The webcast will be listen-only. To ask questions you are invited to
 participate by phone. Within the U.S. dial 800-818-9097. International callers
 dial 785-749-3918.  Caller ID for both is AVANT.
 
     Contact:  Chip Catlin, 781-433-3148
 
     AVANT Immunotherapeutics, Inc. is engaged in the discovery, development
 and commercialization of products that harness the human immune response to
 prevent and treat disease. The company's most advanced therapeutic program
 focuses on compounds with the potential to inhibit inappropriate activation of
 the complement cascade, a vital part of the body's immune defense system.
 AVANT is also developing on its own a portfolio of oral vaccines aimed at
 protecting travelers from diseases endemic in developing areas, as well as a
 proprietary therapeutic vaccine for the management of cholesterol. Through
 corporate collaborations, the company is additionally developing a variety of
 infectious disease vaccines.
 Additional information on AVANT Immunotherapeutics, Inc. can be obtained
 through the Company's site on the World Wide Web: http://www.avantimmune.com.
     (Minimum Requirements to listen to broadcast: The RealPlayer software,
 downloadable free from www.real.com/products/player/index.html, and at least a
 14.4Kbps connection to the Internet.  If you experience problems listening to
 the broadcast, send an email to webmaster@vdat.com.)
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X48329756
 
 SOURCE  AVANT Immunotherapeutics, Inc.